Thrivent Financial For Lutherans Gsk PLC Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$42.05 - $47.77 $27.7 Million - $31.5 Million	659,556 Added 67.6%	1,635,183 $71.2 Million
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $1.95 Million - $2.32 Million	48,569 Added 5.24%	975,627 $42.5 Million
Q4 2021 Feb 16, 2022	BUY	$38.88 - $45.31 $739,497 - $861,796	19,020 Added 2.09%	927,058 $40.9 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $152,444 - $169,618	3,930 Added 0.43%	908,038 $34.7 Million
Q2 2021 Aug 19, 2021	BUY	$36.52 - $41.46 $263,053 - $298,636	7,203 Added 0.8%	904,108 $36 Million
Q1 2021 May 17, 2021	BUY	$34.27 - $40.01 $724,981 - $846,411	21,155 Added 2.42%	896,905 $32 Million
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $1.14 Million - $1.34 Million	-33,560 Reduced 3.69%	875,750 $32.2 Million
Q3 2020 Nov 10, 2020	SELL	$38.11 - $42.99 $602,900 - $680,101	-15,820 Reduced 1.71%	909,310 $34.2 Million
Q2 2020 Aug 12, 2020	BUY	$37.87 - $43.58 $34.7 Million - $39.9 Million	916,051 Added 10089.78%	925,130 $37.7 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $294,795 - $443,327	9,079 New	9,079 $344,000
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $2.31 Million - $2.66 Million	-55,038 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $131,899 - $141,875	-3,260 Reduced 5.59%	55,038 $2.35 Million
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $738,356 - $800,198	18,740 Added 47.37%	58,298 $2.33 Million
Q1 2019 May 14, 2019	SELL	$38.57 - $42.69 $577,007 - $638,642	-14,960 Reduced 27.44%	39,558 $1.65 Million
Q4 2018 Feb 15, 2019	SELL	$37.8 - $42.69 $47.8 Million - $54 Million	-1,263,884 Reduced 95.86%	54,518 $2.08 Million
Q3 2018 Nov 15, 2018	BUY	$39.75 - $42.69 $350,197 - $376,098	8,810 Added 0.67%	1,318,402 $53 Million
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $2.29 Million - $2.47 Million	-57,848 Reduced 4.23%	1,309,592 $52.8 Million
Q1 2018 May 08, 2018	SELL	$36.18 - $40.15 $3.31 Million - $3.68 Million	-91,625 Reduced 6.28%	1,367,440 $53.4 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $1.69 Million - $2 Million	-47,788 Reduced 3.17%	1,459,065 $51.8 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $59.4 Million - $62.6 Million	1,506,853	1,506,853 $61.2 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account